![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
Fartcoin (FARTCOIN) has staged a remarkable rally, climbing nearly 9.76% in the past 24 hours to trade around $0.9090
Fartcoin (FARTCOIN) staged a notable rally on Thursday, climbing nearly 9.76% in the past 24 hours to trade around $0.9090 by 03:28 ET (07:28 GMT). This jump in price followed a report by blockchain analytics firm Lookonchain about a whale who previously lost $701,000 on Fartcoin. The firm said the whale had once again dived into the token, spending 14,725 SOL ($1.98 million) to acquire 2.22 million FARTCOIN at $0.89.
This time, however, the tale unfolded with a different ending.
He sold 2.69M $Fartcoin($2.47M) at $0.92 3 hours ago, making a $127K profit.https://t.co/4YOOWwYVoz https://t.co/hFmdUNnS04 pic.twitter.com/OZt2Yp3KDw— Lookonchain (@lookonchain) April 21, 2025At the time, the wallet was in the red by $297,000, a narrative of continued losses. But fast-forward to April 21, and the tables have turned. The wallet sold 2.69 million FARTCOIN ($2.47 million) at $0.92, locking in a $127,000 profit, revealed Lookonchain.
The whale’s decision to sell slightly above his entry price paid off, not only validating his conviction but also stirring increased market confidence in the asset.
Moreover, another whale entered the scene on April 20, scooping up 2 million FARTCOIN for $1.7 million at an average of $0.85 per token. While this second entity has yet to take profit, their entry suggests that smart money anticipates more upside in the near term.
A whale bought 2M $Fartcoin($1.7M) at an average price of $0.85 7 hours ago.https://t.co/DG6w1OlWSRpic.twitter.com/WGA1goinYH— Lookonchain (@lookonchain) April 20, 2025Fartcoin Price Analysis: Technical Breakdown
Looking at the daily FARTCOIN daily chart, the price action is moving cleanly inside a parallel ascending channel, a structure that often hints at a continuation trend with predictable support and resistance levels.
Fartcoin Price Chart | Source: TradingView
Support & Resistance:
Immediately, support lies near $0.82, the lower trendline of the channel and also in confluence with the 0.618 Fibonacci retracement.
Immediately above, resistance is just overhead at $0.93–$0.95, right near the upper trendline.
The current upward momentum suggests a possible breakout above this resistance zone. If bulls manage to hold above $0.95, the next Fibonacci-based targets emerge at:
The MACD Indicator shows a bullish crossover that’s just beginning to cool off slightly, but no strong bearish divergence is present yet. This supports the case for potential continuation of the upward trajectory.
If the price breaks down below the lower channel support near $0.82, eyes will turn to the 0.786 ($0.71) and 0.618 ($0.58) Fib levels for potential catch zones.
A break below $0.55 would invalidate the bullish structure and likely usher in deeper correction towards the $0.46 or even $0.35 levels.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
-
- Blurring the Lines Between Decentralized Finance and Traditional Finance, Ripple's XRP Ledger (XRPL) Is at the Center of a New Attempt to Integrate Blockchain into the Heart of Institutional Trading
- Apr 21, 2025 at 11:50 pm
- The lines between decentralized finance and traditional finance continue to blur now, Ripple's XRP Ledger (XRPL) is at the center of a new attempt to integrate blockchain into the heart of institutional trading.
-
-
-
- Novo Nordisk (NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019. Yet the stock has since plummeted 60% from its peak value.
- Apr 21, 2025 at 11:45 pm
- Despite strong growth and earnings momentum, the Danish biotech giant faces scrutiny over its positioning in the rapidly changing market for GLP-1 receptor agonists, as competition intensifies.
-
-
-